Researchers propose a dual CA19-9 cut-off strategy that identifies both high-risk pancreatic cancer patients and Lewis antigen-negative “nonproducers” who may otherwise be incorrectly classified as low risk. The post Dual CA19-9 Threshold Improves Risk Stratification in Pancreatic Cancer appeared first on Inside Precision Medicine .